A significant breakthrough in cancer study is emerging with the use of mini-antibodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in various forms of tumors, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research